Detailed information for compound 369080

Basic information

Technical information
  • TDR Targets ID: 369080
  • Name: N-[[4-[4-(piperidine-1-carbonyl)-1,3-oxazol-2 -yl]phenyl]methyl]-2-[4-(trifluoromethoxy)phe nyl]acetamide
  • MW: 487.471 | Formula: C25H24F3N3O4
  • H donors: 1 H acceptors: 3 LogP: 4.53 Rotable bonds: 10
    Rule of 5 violations (Lipinski): 1
  • SMILES: O=C(Cc1ccc(cc1)OC(F)(F)F)NCc1ccc(cc1)c1occ(n1)C(=O)N1CCCCC1
  • InChi: 1S/C25H24F3N3O4/c26-25(27,28)35-20-10-6-17(7-11-20)14-22(32)29-15-18-4-8-19(9-5-18)23-30-21(16-34-23)24(33)31-12-2-1-3-13-31/h4-11,16H,1-3,12-15H2,(H,29,32)
  • InChiKey: OQOXEZJPPFSYQB-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • N-[[4-[4-(piperidine-1-carbonyl)oxazol-2-yl]phenyl]methyl]-2-[4-(trifluoromethoxy)phenyl]acetamide
  • N-[[4-[4-[oxo(1-piperidyl)methyl]-2-oxazolyl]phenyl]methyl]-2-[4-(trifluoromethoxy)phenyl]acetamide
  • N-[[4-(4-piperidin-1-ylcarbonyl-1,3-oxazol-2-yl)phenyl]methyl]-2-[4-(trifluoromethoxy)phenyl]ethanamide
  • N-[4-[4-(piperidine-1-carbonyl)oxazol-2-yl]benzyl]-2-[4-(trifluoromethoxy)phenyl]acetamide
  • N-[[4-[4-[oxo-(1-piperidyl)methyl]-2-oxazolyl]phenyl]methyl]-2-[4-(trifluoromethoxy)phenyl]acetamide

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Echinococcus granulosus serine:threonine protein kinase PLK1 0.0095 0.7758 1
Echinococcus multilocularis serine:threonine protein kinase PLK1 0.0095 0.7758 1
Schistosoma mansoni kinase 0.0048 0.3578 0.4613
Echinococcus multilocularis tar DNA binding protein 0.0065 0.5052 0.6513
Schistosoma mansoni ap endonuclease 0.0018 0.0902 0.1163
Echinococcus multilocularis DNA (apurinic or apyrimidinic site) lyase 0.0018 0.0902 0.1163
Wolbachia endosymbiont of Brugia malayi exonuclease III 0.0018 0.0902 1
Trypanosoma brucei polo-like protein kinase 0.0095 0.7758 1
Trichomonas vaginalis CAMK family protein kinase 0.0047 0.3466 0.4468
Trichomonas vaginalis CAMK family protein kinase 0.0095 0.7758 1
Onchocerca volvulus Serine\/threonine kinase homolog 0.0095 0.7758 0.5
Mycobacterium ulcerans exodeoxyribonuclease III protein XthA 0.0018 0.0902 1
Loa Loa (eye worm) MH2 domain-containing protein 0.012 1 1
Echinococcus granulosus tar DNA binding protein 0.0065 0.5052 0.6513
Loa Loa (eye worm) RNA binding protein 0.0065 0.5052 0.4561
Trypanosoma cruzi polo-like protein kinase, putative 0.0095 0.7758 1
Trichomonas vaginalis CAMK family protein kinase 0.0095 0.7758 1
Trichomonas vaginalis CAMK family protein kinase 0.0047 0.3466 0.4468
Trichomonas vaginalis CAMK family protein kinase 0.0095 0.7758 1
Toxoplasma gondii exonuclease III APE 0.0018 0.0902 0.5
Trichomonas vaginalis CAMK family protein kinase 0.0095 0.7758 1
Brugia malayi RNA binding protein 0.0065 0.5052 0.4561
Schistosoma mansoni tar DNA-binding protein 0.0065 0.5052 0.6513
Mycobacterium tuberculosis Probable exodeoxyribonuclease III protein XthA (exonuclease III) (EXO III) (AP endonuclease VI) 0.0018 0.0902 1
Schistosoma mansoni tar DNA-binding protein 0.0065 0.5052 0.6513
Trichomonas vaginalis ap endonuclease, putative 0.0018 0.0902 0.1163
Loa Loa (eye worm) PLK/PLK1 protein kinase 0.0095 0.7758 0.7535
Plasmodium falciparum AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative 0.0018 0.0902 0.5
Trichomonas vaginalis ap endonuclease, putative 0.0018 0.0902 0.1163
Trichomonas vaginalis CAMK family protein kinase 0.0095 0.7758 1
Schistosoma mansoni tar DNA-binding protein 0.0065 0.5052 0.6513
Brugia malayi TAR-binding protein 0.0065 0.5052 0.4561
Brugia malayi serine/threonine-protein kinase plk-2 0.0095 0.7758 0.7535
Leishmania major protein kinase, putative,polo-like protein kinase, putative 0.0095 0.7758 1
Trichomonas vaginalis CAMK family protein kinase 0.0095 0.7758 1
Plasmodium vivax AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative 0.0018 0.0902 0.5
Brugia malayi RNA recognition motif domain containing protein 0.0065 0.5052 0.4561
Schistosoma mansoni tar DNA-binding protein 0.0065 0.5052 0.6513
Entamoeba histolytica serine/threonine protein kinase, putative 0.0095 0.7758 1
Loa Loa (eye worm) TAR-binding protein 0.0065 0.5052 0.4561
Schistosoma mansoni ap endonuclease 0.0018 0.0902 0.1163
Loa Loa (eye worm) RNA recognition domain-containing protein domain-containing protein 0.0065 0.5052 0.4561
Giardia lamblia Kinase, PLK 0.0095 0.7758 1
Trichomonas vaginalis CAMK family protein kinase 0.0095 0.7758 1
Echinococcus granulosus DNA apurinic or apyrimidinic site lyase 0.0018 0.0902 0.1163
Treponema pallidum exodeoxyribonuclease (exoA) 0.0018 0.0902 1
Schistosoma mansoni serine/threonine protein kinase 0.0095 0.7758 1
Schistosoma mansoni tar DNA-binding protein 0.0065 0.5052 0.6513
Mycobacterium leprae PROBABLE BACTERIOFERRITIN BFRA 0.0008 0 0.5
Trypanosoma cruzi polo-like protein kinase, putative 0.0095 0.7758 1
Loa Loa (eye worm) transcription factor SMAD2 0.012 1 1

Activities

Activity type Activity value Assay description Source Reference
Activity (functional) 0 Activity against caspase-mediated PARP cleavage in human DLD1 cells at 1 uM after 48 hrs by Western blot analysis ChEMBL. 16784854
Activity (functional) 0 Activity against DNA laddering in DLD1 cells at 1 uM after 48 hrs ChEMBL. 16784854
EC50 (functional) = 270 nM Induction of apoptosis in human DLD1 cells assessed as activation of caspases by HTS assay ChEMBL. 16784854
EC50 (functional) = 270 nM Induction of apoptosis in human DLD1 cells assessed as activation of caspases by HTS assay ChEMBL. 16784854
GI50 (functional) = 229 nM Growth inhibition of human DLD1 cells ChEMBL. 16784854
GI50 (functional) = 229 nM Growth inhibition of human DLD1 cells ChEMBL. 16784854
Inhibition (functional) = 21 % Inhibition of tumor growth in BALB/c nude mouse implanted with DLD1 cells at 50 mg/kg, ip, qd ChEMBL. 16784854
Inhibition (functional) = 21 % Inhibition of tumor growth in BALB/c nude mouse implanted with DLD1 cells at 50 mg/kg, ip, qd ChEMBL. 16784854
Inhibition (functional) = 38 % Inhibition of tumor growth in BALB/c nude mouse implanted with DLD1 cells at 100 mg/kg, ip, qd ChEMBL. 16784854
Inhibition (functional) = 38 % Inhibition of tumor growth in BALB/c nude mouse implanted with DLD1 cells at 100 mg/kg, ip, qd ChEMBL. 16784854
Inhibition (functional) = 63 % Inhibition of tumor growth in BALB/c nude mouse implanted with DLD1 cells at 50 mg/kg, ip, bid ChEMBL. 16784854
Inhibition (functional) = 63 % Inhibition of tumor growth in BALB/c nude mouse implanted with DLD1 cells at 50 mg/kg, ip, bid ChEMBL. 16784854
Solubility = 44 uM Solubility of the compound ChEMBL. 16784854

Phenotypes

Whole-cell/tissue/organism interactions

Species name Source Reference Is orphan
Homo sapiens ChEMBL23 16784854

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.